Growth Metrics

Ironwood Pharmaceuticals (IRWD) Change in Receivables (2016 - 2026)

Ironwood Pharmaceuticals' Change in Receivables history spans 16 years, with the latest figure at -$73.6 million for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 1395.27% to -$73.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$35.1 million, a 25.59% increase, with the full-year FY2025 number at -$35.1 million, up 25.59% from a year prior.
  • Change in Receivables hit -$73.6 million in Q4 2025 for Ironwood Pharmaceuticals, down from $34.2 million in the prior quarter.
  • Over the last five years, Change in Receivables for IRWD hit a ceiling of $46.4 million in Q2 2025 and a floor of -$73.6 million in Q4 2025.
  • Historically, Change in Receivables has averaged -$5.0 million across 5 years, with a median of $1.5 million in 2021.
  • Biggest five-year swings in Change in Receivables: soared 4405.71% in 2022 and later plummeted 1395.27% in 2025.
  • Tracing IRWD's Change in Receivables over 5 years: stood at $12.4 million in 2021, then tumbled by 107.55% to -$937000.0 in 2022, then skyrocketed by 588.47% to $4.6 million in 2023, then grew by 24.19% to $5.7 million in 2024, then plummeted by 1395.27% to -$73.6 million in 2025.
  • Business Quant data shows Change in Receivables for IRWD at -$73.6 million in Q4 2025, $34.2 million in Q3 2025, and $46.4 million in Q2 2025.